News Focus
News Focus
Followers 46
Posts 2353
Boards Moderated 0
Alias Born 06/11/2020

Re: ShortsRClowns post# 3292

Friday, 10/01/2021 6:44:56 AM

Friday, October 01, 2021 6:44:56 AM

Post# of 4271
Merk's drug only shows a 50% efficacy rate....

per news today.However it being the first of it's kind and study results being released first gets the "first Praise"....Wait until Tempol results are know, Interim analysis and we will see what ADMP's TEMPOL looks like for efficacy....

Safety profile is there as well as 2300 papers written on Tempol..


Tic Toc..Geesh 50% efficacy...LOWER THAN THE VACCINES RATES!! ALL OF THEM..

Pom Pom not needed for 50% rate...jmho...GO ADMP>............

https://www.merck.com/news/merck-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderat/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y